Advertisment
|
|
|
news roundup
Novogen’s Cantrixil Phase I clinical trial will be conducted in patients with refractory/recurrent peritoneal malignancies with malignant ascites, including ovarian cancer.
Infinity will now utilize Medidata’s RBM solution in an upcoming Phase III oncology study for patients with indolent non-Hodgkin lymphoma.
Ignyta, a precision oncology biotech, and the European Organization for Research and Treatment of Cancer will collaborate via EORTC’s Screening Patients for Efficient Clinical Trial Access (SPECTA) biomarker screening initiative to identify patients into its global Phase II clinical study.
|
|
|
|
Advertisment
|
|
|
articles
New molecular entity (NME) selection, protocol development, patient population, and principal investigator (PI) and site selection are key areas in which to focus to establish a foundation for the successful execution of an early phase oncology trial.
Engaging physicians, sites, staff and patients in the clinical trial process is crucial in moving forward with new and effective oncology therapies. Accruing patients depends greatly on engaged, enthusiastic PIs, as they are the gatekeepers in helping patients decide to participate in clinical trials. Building staff awareness and enthusiasm are also essential for retaining participants.
advertisment
|
|
|
blogs
From an aggregated standpoint, median oncology clinical trial duration increased by 69% from 2002-2014, an average increase of 16 months.
|
|
|
Advertisment
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
| advertisment
Advanced Visual Analytics for Efficient Risk Based Monitoring
Live Webinar: Thursday, December 10, 2015 at 10:00 AM Eastern Standard Time
In this webinar, Saritta Hines, Principal Clinical Programmer at Allergan, will present how PerkinElmer’s Solution for Clinical Development Operations—powered by TIBCO Spotfire®—is the ideal platform for RBM enabling optimal trial oversight through real-time risk assessment. She will show how to incorporate Key Risk Indicators into interactive dashboards and use advanced TIBCO Spotfire® features including property controls, map features and the embedding of dashboards into responsive web pages.
 Register Free
|
|
|
|
|
|
